Tezepelumab: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Tezepelumab. Educational only — not medical advice.
Labeled uses
TEZSPIRE is indicated for the add-on maintenance treatment of adult and pediatric patients aged 12 years and older with severe asthma. Limitations of Use: TEZSPIRE is not indicated for the relief of acute bronchospasm or status asthmaticus.
Source: FDA labeling via NIH DailyMed (set 60f0aa03…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.